SEC Filings TLDR

Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.

Currently we only process 8-K, 6-K, Schedule 13G. We will support more forms in the future.

2025-10-27RACE6-KFerrari N.V. Share Buyback Program Updateshareholder relatedMEDIUM
Ferrari N.V. (NYSE/EXM: RACE) has provided an update on its share buyback program. The company has purchased 51,100 common shares on the Euronext Milan (EXM) as part of the eighth tranche of its multi-year share buyback program, which was announced on July 31, 2025. The total consideration for these purchases was €17,5...
2025-10-27FSM6-KFortuna Mining Corp. to Release Q3 2025 Financial ResultsearningsMEDIUM
Fortuna Mining Corp. (NYSE: FSM | TSX: FVI) announced that it will release its financial statements and MD&A for the third quarter of 2025 on November 5, 2025, after market close. A conference call to discuss the financial and operational results will be held on November 6, 2025, at 9:00 a.m. Pacific time | 12:00 p.m. ...
2025-10-27EVAX6-KEvaxion A/S Appoints New CEOofficer / director changeMEDIUM
Evaxion A/S, a clinical-stage TechBio company specializing in AI-Immunology™ powered vaccines, announced the appointment of Dr. Helen Tayton-Martin as its new Chief Executive Officer (CEO) effective November 24, 2025. Dr. Tayton-Martin brings over 30 years of experience in biotech, including leadership roles in cancer ...
2025-10-27ELBM6-KElectra Advances Idaho Cobalt-Copper Assetsoperation relatedMEDIUM
Electra Battery Materials Corporation has initiated a new program to advance mineral deposit modeling and feedstock integration at its Iron Creek cobalt-copper project in Idaho. This move supports U.S. efforts to onshore critical mineral production and reduce dependence on foreign supply chains. The company has complet...
2025-10-27ELPC6-KSpecial Meeting of Preferred Shareholders for PN Conversion Ratificationshareholder relatedHIGH
Companhia Paranaense de Energia (Copel) has convened a Special Meeting of Preferred Shareholders to be held on October 17, 2025, to ratify the mandatory conversion of all preferred shares (PN) into common shares and class 'C' preferred shares (PNC). This conversion is part of the company's migration to the Novo Mercado...
2025-10-27ELPC6-KCopel Announces Special Meeting for Preferred Shareholders to Ratify Share Conversionshareholder relatedMEDIUM
Companhia Paranaense de Energia (Copel) has convened a special meeting of preferred shareholders (AGESP PN) to ratify the mandatory conversion of all preferred shares into common shares and new class 'C' preferred shares (PNC). This meeting, scheduled for November 17, 2025, is part of the company's transition to the No...
2025-10-27ELPC6-KCopel Calls Special Meeting of Preferred Shareholdersshareholder relatedMEDIUM
Companhia Paranaense de Energia (Copel) has announced a Special Meeting of Preferred Shareholders to be held on November 17, 2025, via the Ten Meetings digital platform. The primary agenda is the ratification of the mandatory conversion of all preferred shares (PN) into common shares and class 'C' preferred shares (PNC...
2025-10-27ELPC6-KCOPEL Calls Special Meeting for Preferred Shareholdersshareholder relatedMEDIUM
Companhia Paranaense de Energia (COPEL) has announced the call for a Special Meeting of Preferred Shareholders (AGESP PN) to be held on November 17, 2025. The meeting aims to ratify the mandatory conversion of all Preferred Shares (PN) into Common Shares and Class C Shares (PNC). This conversion is part of the company'...
2025-10-27CIG6-KCEMIG Q2 2025 Results: Strategic Concession Extensions, Adjusted Profit Growth, and Debt ManagementearningsHIGH
Energy Company of Minas Gerais (CEMIG) filed its Q2 2025 results, reporting a net profit of R$1.19 billion (-29.6% YoY) driven by higher energy costs and regulatory adjustments. Adjusted net profit rose 16.6% to R$1.32 billion, reflecting tariff adjustments and cost controls. Key developments include winning a CCEE auc...
2025-10-27ESLT6-KElbit Systems to Report Third Quarter 2025 Financial ResultsearningsMEDIUM
Elbit Systems Ltd. announced that it will publish its third quarter 2025 financial results on November 18, 2025. The company will host a conference call on the same day at 9:00am Eastern Time to discuss the results. Participants can join the call via various dial-in numbers, and the call will also be broadcast live on ...
2025-10-27EDN6-KS&P Upgrades Edenor's National Scale and Global Notes Program Ratingsfinancial obligation triggerMEDIUM
Empresa Distribuidora y Comercializadora Norte S.A. (Edenor) announced that S&P has upgraded the company’s national scale rating and its Global Notes Program rating from raBBB- to raA+, maintaining a stable outlook. This upgrade reflects an improvement in the company's creditworthiness and financial stability. The noti...
2025-10-27DDI6-KDoubleDown Interactive to Report 2025 Third Quarter ResultsearningsMEDIUM
DoubleDown Interactive Co., Ltd. announced that it will release its unaudited financial results for the third quarter ended September 30, 2025, on November 10, 2025. The company will host a conference call and webcast at 5:00 p.m. Eastern Time on the same day to discuss the financial results. The call and webcast are o...
2025-10-27RDY6-KDr. Reddy’s Laboratories Limited Q3 2025 Financial ResultsearningsLOW
Dr. Reddy’s Laboratories Limited has submitted its unaudited financial results for the quarter and half-year ended September 30, 2025, as required by Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation, 2015. The results were published in the Financia...
2025-10-27RDY6-KDr. Reddy’s Laboratories Earnings Call Recording SubmissionearningsMEDIUM
Dr. Reddy’s Laboratories Limited has submitted a Form 6-K to the SEC, providing the audio recordings of their earnings call for the quarter ended September 30, 2025. The earnings call was conducted on October 24, 2025, and the submission includes a weblink to access the audio recordings. This filing is in compliance wi...
2025-10-27DQ6-KDaqo New Energy Announces Q3 2025 Financial ResultsearningsHIGH
Daqo New Energy Corp. reported its unaudited financial results for the third quarter of 2025. The company saw significant improvements in key financial metrics compared to the previous quarter. Revenue increased to $244.6 million from $75.2 million in Q2 2025, driven by higher polysilicon sales volume and average selli...
2025-10-27CVAC6-KCureVac N.V. Announces Extraordinary General Meeting for Merger with BioNTech SEM&A / divestitureHIGH
CureVac N.V. has convened an extraordinary general meeting of shareholders to be held on November 25, 2025, to discuss and vote on the proposed merger with BioNTech SE. The meeting will address several key items, including the legal merger of CureVac with CureVac Merger B.V., the subsequent sale and transfer of shares ...
2025-10-27CLGN6-KCollPlant Expands rhCollagen Distribution in North Americaoperation relatedMEDIUM
CollPlant Biotechnologies Ltd. announced the expansion of its distribution capabilities in the United States and Canada through a new partnership with a U.S.-based logistics center. The center, scheduled to become operational this quarter, will provide cGMP-compliant storage and distribution services, serving as a clin...
2025-10-27CMND6-KClearmind Medicine Appoints Mary-Elizabeth Gifford as Chief of Global Impactofficer / director changeMEDIUM
Clearmind Medicine Inc. announced the appointment of Mary-Elizabeth Gifford as Chief of Global Impact. Gifford will lead efforts to strengthen US partnerships, governmental and regulatory advocacy, and strategic alliances. She brings extensive experience in psychedelic policies and regulatory landscapes, having previou...
2025-10-27CRDL6-KCardiol Therapeutics Completes US$11.4 Million Private Placement to Fund Clinical Developmentequity offeringHIGH
Cardiol Therapeutics Inc. closed a US$11.4 million private placement offering of units, extending its cash runway into Q3 2027. The funds will support the Phase III MAVERIC trial investigating CardiolRx™ for recurrent pericarditis (which holds FDA Orphan Drug Designation) and development of CRD-38, a subcutaneous thera...
2025-10-27IMOS6-KClarification of Taiwan Media Report on DRAM Business Growthoperation relatedLOW
ChipMOS TECHNOLOGIES INC. issued a clarification regarding a Taiwan media report on October 27, 2025. The media report stated that the Company's DRAM business is expected to maintain a double-digit growth rate in 2025. The Company emphasized that all financial and business information should be referred to its official...
2025-10-27CRNT6-KCeragon Networks to Participate in Upcoming Investor Conferencesoperation relatedLOW
Ceragon Networks Ltd. (NASDAQ: CRNT) announced that its management will participate in several investor conferences in November 2025. These include the Craig-Hallum Alpha Select Conference on November 18 in New York City, the ROTH Technology Conference on November 19 in New York City, and the Needham Tech Week on Novem...
2025-10-27CVE6-KCenovus Energy Inc. Amending Agreement with MEG Energy Corp.M&A / divestitureMEDIUM
Cenovus Energy Inc. and MEG Energy Corp. have entered into an Amending Agreement dated October 26, 2025, to modify the terms of their previously established Arrangement Agreement. The key amendments include an increase in the Cash Offer Price to $30.00, raising the Aggregate Consideration to $7,631,341,050, and adjusti...
2025-10-27CVE6-KCenovus Energy Announces Amendment to MEG Energy Acquisition AgreementM&A / divestitureHIGH
Cenovus Energy Inc. has entered into a second amending agreement regarding its arrangement to acquire MEG Energy Corp. The amended terms allow MEG shareholders to elect to receive either $30.00 in cash or 1.255 Cenovus common shares per MEG share, subject to pro-ration based on a maximum of $3.8 billion in cash and 159...
2025-10-27BREA6-KBrera Holdings PLC Acquisition of Juve Stabia and Financial StatementsM&A / divestitureMEDIUM
Brera Holdings PLC, a foreign private issuer, filed a Form 6-K report with the SEC for the month of October 2025. The report includes the condensed consolidated interim financial statements as of June 30, 2025, and December 31, 2024, along with the financial statements for the six months ended June 30, 2025, and 2024. ...
2025-10-27BWAY6-KBrainsWay Announces Minority-Stake Investments in U.S. Mental Health ProvidersM&A / divestitureMEDIUM
BrainsWay Ltd., a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, has announced two additional minority-stake investments in U.S. mental health providers. The investments include an equity financing agreement with Tangient ATX Inc., which services the Heading Health mental...